Kezar Life Sciences Inc.
News
Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Business Wire Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...\n more…
Kezar Life Sciences, Inc. (NASDAQ:KZR) Short Interest Update
Ticker Report Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totalling 1,040,000 shares, a...\n more…
Vanguard Group Inc. Buys 30,740 Shares of Kezar Life Sciences, Inc. (NASDAQ:KZR)
Ticker Report Vanguard Group Inc. increased its stake in shares of Kezar Life Sciences, Inc. (NASDAQ:KZR - Free Report) by 1.0% during the 1st quarter, according to the company in its most recent disclosure with...\n more…
Equities Analysts Issue Forecasts for Kezar Life Sciences, Inc.'s Q3 2024 Earnings (NASDAQ:KZR)
Zolmax Kezar Life Sciences, Inc. (NASDAQ:KZR - Free Report) - Stock analysts at William Blair boosted their Q3 2024 EPS estimates for Kezar Life Sciences in a research report issued on Tuesday, August...\n more…
